亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

EULAR recommendations for the management of systemic lupus erythematosus: 2023 update

医学 贝里穆马布 硫唑嘌呤 美罗华 羟基氯喹 狼疮性肾炎 任天堂 依法利珠单抗 阿巴塔克普 系统性红斑狼疮 强的松 维持疗法 重症监护医学 内科学 免疫学 疾病 英夫利昔单抗 特发性肺纤维化 B细胞激活因子 B细胞 2019年冠状病毒病(COVID-19) 淋巴瘤 传染病(医学专业) 抗体 化疗
作者
Antonis Fanouriakis,Myrto Kostopoulou,Jeanette Andersen,Martin Aringer,Laurent Arnaud,Sang Cheol Bae,John Boletis,Ian N. Bruce,Ricard Cervera,Andrea Doria,Thomas Dörner,Richard Furie,Dafna Gladman,Frédéric Houssiau,Luís Inês,David Jayne,Marios Kouloumas,László Kovács,Chi Chiu Mok,Eric Morand,Gabriella Moroni,Marta Mosca,Johanna Mücke,Chetan Mukhtyar,György Nagy,Sandra V. Navarra,Ioannis Parodis,José María Pego-Reigosa,Michelle Petri,Bernardo A Pons-Éstel,Matthias Schneider,Josef S. Smolen,Elisabet Svenungsson,Yoshiya Tanaka,Maria G. Tektonidou,Y K Onno Teng,Anǵela Tincani,Edward M Vital,Ronald van Vollenhoven,Chris Wincup,George Βertsias,Dimitrios T. Boumpas
出处
期刊:Annals of the Rheumatic Diseases [BMJ]
卷期号:83 (1): 15-29 被引量:40
标识
DOI:10.1136/ard-2023-224762
摘要

Objectives To update the EULAR recommendations for the management of systemic lupus erythematosus (SLE) based on emerging new evidence. Methods An international Task Force formed the questions for the systematic literature reviews (January 2018–December 2022), followed by formulation and finalisation of the statements after a series of meetings. A predefined voting process was applied to each overarching principle and recommendation. Levels of evidence and strengths of recommendation were assigned, and participants finally provided their level of agreement with each item. Results The Task Force agreed on 5 overarching principles and 13 recommendations, concerning the use of hydroxychloroquine (HCQ), glucocorticoids (GC), immunosuppressive drugs (ISDs) (including methotrexate, mycophenolate, azathioprine, cyclophosphamide (CYC)), calcineurin inhibitors (CNIs, cyclosporine, tacrolimus, voclosporin) and biologics (belimumab, anifrolumab, rituximab). Advice is also provided on treatment strategies and targets of therapy, assessment of response, combination and sequential therapies, and tapering of therapy. HCQ is recommended for all patients with lupus at a target dose 5 mg/kg real body weight/day, considering the individual’s risk for flares and retinal toxicity. GC are used as ‘bridging therapy’ during periods of disease activity; for maintenance treatment, they should be minimised to equal or less than 5 mg/day (prednisone equivalent) and, when possible, withdrawn. Prompt initiation of ISDs (methotrexate, azathioprine, mycophenolate) and/or biological agents (anifrolumab, belimumab) should be considered to control the disease and facilitate GC tapering/discontinuation. CYC and rituximab should be considered in organ-threatening and refractory disease, respectively. For active lupus nephritis, GC, mycophenolate or low-dose intravenous CYC are recommended as anchor drugs, and add-on therapy with belimumab or CNIs (voclosporin or tacrolimus) should be considered. Updated specific recommendations are also provided for cutaneous, neuropsychiatric and haematological disease, SLE-associated antiphospholipid syndrome, kidney protection, as well as preventative measures for infections, osteoporosis, cardiovascular disease. Conclusion The updated recommendations provide consensus guidance on the management of SLE, combining evidence and expert opinion.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
我是老大应助Feng采纳,获得10
6秒前
6秒前
李剑鸿发布了新的文献求助300
17秒前
周周发布了新的文献求助10
22秒前
大个应助savagecas采纳,获得10
44秒前
57秒前
suruo完成签到,获得积分10
57秒前
savagecas发布了新的文献求助10
1分钟前
2分钟前
duchunxia发布了新的文献求助10
2分钟前
香蕉觅云应助duchunxia采纳,获得10
2分钟前
Jasper应助科研通管家采纳,获得10
2分钟前
wangfaqing942完成签到 ,获得积分10
3分钟前
俏皮的安萱完成签到 ,获得积分10
3分钟前
aaaaa发布了新的文献求助10
4分钟前
4分钟前
Shuang发布了新的文献求助10
4分钟前
小金星星完成签到 ,获得积分10
4分钟前
4分钟前
tianyue发布了新的文献求助10
4分钟前
wanci应助tianyue采纳,获得10
5分钟前
5分钟前
冷傲世立完成签到 ,获得积分10
5分钟前
Eatanicecube发布了新的文献求助10
5分钟前
Parotodus完成签到 ,获得积分10
6分钟前
6分钟前
Eatanicecube完成签到,获得积分10
6分钟前
李李李完成签到 ,获得积分10
6分钟前
周周发布了新的文献求助10
6分钟前
772829完成签到 ,获得积分10
7分钟前
7分钟前
清楚或青月完成签到 ,获得积分10
7分钟前
8分钟前
8分钟前
duchunxia发布了新的文献求助10
8分钟前
周周完成签到,获得积分10
8分钟前
YAOYAO发布了新的文献求助10
8分钟前
周周发布了新的文献求助10
8分钟前
搜集达人应助科研通管家采纳,获得10
8分钟前
any完成签到 ,获得积分10
9分钟前
高分求助中
Manual of Clinical Microbiology, 4 Volume Set (ASM Books) 13th Edition 1000
Edestus (Chondrichthyes, Elasmobranchii) from the Upper Carboniferous of Xinjiang, China 500
Chinese-English Translation Lexicon Version 3.0 500
Electronic Structure Calculations and Structure-Property Relationships on Aromatic Nitro Compounds 500
マンネンタケ科植物由来メロテルペノイド類の網羅的全合成/Collective Synthesis of Meroterpenoids Derived from Ganoderma Family 500
[Lambert-Eaton syndrome without calcium channel autoantibodies] 440
Two-sample Mendelian randomization analysis reveals causal relationships between blood lipids and venous thromboembolism 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 有机化学 工程类 生物化学 纳米技术 物理 内科学 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 电极 光电子学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 2380946
求助须知:如何正确求助?哪些是违规求助? 2088241
关于积分的说明 5244346
捐赠科研通 1815259
什么是DOI,文献DOI怎么找? 905728
版权声明 558821
科研通“疑难数据库(出版商)”最低求助积分说明 483664